Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Validity of reduced radiation dose for localized diffuse large B-cell lymphoma showing a good response to chemotherapy.

Koiwai K, Sasaki S, Yoshizawa E, Ina H, Fukazawa A, Sakai K, Ozawa T, Matsushita H, Kadoya M.

J Radiat Res. 2014 Mar 1;55(2):359-63. doi: 10.1093/jrr/rrt122. Epub 2013 Nov 1.

PMID:
24187329
[PubMed - in process]
Free PMC Article
2.

Radiotherapy dose-response analysis for diffuse large B-cell lymphoma with a complete response to chemotherapy.

Dorth JA, Prosnitz LR, Broadwater G, Beaven AW, Kelsey CR.

Radiat Oncol. 2012 Jun 21;7:100. doi: 10.1186/1748-717X-7-100.

PMID:
22720801
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

R-CHOP with dose-attenuated radiation therapy could induce good prognosis in gastric diffuse large B cell lymphoma.

Mishima Y, Terui Y, Yokoyama M, Nishimura N, Sakajiri S, Ueda K, Kuboki Y, Nakano K, Suzuki K, Nara E, Tsuyama N, Takeuchi K, Oguchi M, Hatake K.

Exp Hematol Oncol. 2012 Sep 24;1(1):30. doi: 10.1186/2162-3619-1-30.

PMID:
23210663
[PubMed]
Free PMC Article
4.

Locoregional irradiation for inflammatory breast cancer: effectiveness of dose escalation in decreasing recurrence.

Liao Z, Strom EA, Buzdar AU, Singletary SE, Hunt K, Allen PK, McNeese MD.

Int J Radiat Oncol Biol Phys. 2000 Jul 15;47(5):1191-200.

PMID:
10889372
[PubMed - indexed for MEDLINE]
5.

The outcome of combined-modality treatments for stage I and II primary large B-cell lymphoma of the mediastinum.

Nguyen LN, Ha CS, Hess M, Romaguera JE, Manning JT, Cabanillas F, Cox JD.

Int J Radiat Oncol Biol Phys. 2000 Jul 15;47(5):1281-5.

PMID:
10889382
[PubMed - indexed for MEDLINE]
6.

Localized aggressive non-Hodgkin's lymphoma of the nasal cavity: a survey by the Japan Lymphoma Radiation Therapy Group.

Shikama N, Ikeda H, Nakamura S, Oguchi M, Isobe K, Hirota S, Hasegawa M, Nakamura K, Sasai K, Hayabuchi N.

Int J Radiat Oncol Biol Phys. 2001 Dec 1;51(5):1228-33.

PMID:
11728681
[PubMed - indexed for MEDLINE]
7.

Impact of consolidation radiation therapy in stage III-IV diffuse large B-cell lymphoma with negative post-chemotherapy radiologic imaging.

Dorth JA, Prosnitz LR, Broadwater G, Diehl LF, Beaven AW, Coleman RE, Kelsey CR.

Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):762-7. doi: 10.1016/j.ijrobp.2011.12.067. Epub 2012 Mar 13.

PMID:
22420972
[PubMed - indexed for MEDLINE]
8.

Consolidation radiotherapy following brief chemotherapy for localized diffuse large B-cell lymphoma: a prospective study.

Isobe K, Kawakami H, Tamaru J, Yasuda S, Uno T, Aruga T, Kawata T, Shigematsu N, Hatano K, Takagi T, Mikata A, Ito H.

Leuk Lymphoma. 2003 Sep;44(9):1535-9.

PMID:
14565656
[PubMed - indexed for MEDLINE]
9.

Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy.

Zhang Z, Liao Z, Jin J, Ajani J, Chang JY, Jeter M, Guerrero T, Stevens CW, Swisher S, Ho L, Yao J, Allen P, Cox JD, Komaki R.

Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):656-64.

PMID:
15708243
[PubMed - indexed for MEDLINE]
10.

Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.

Guo Y, Lu JJ, Ma X, Wang B, Hong X, Li X, Li J.

Oral Oncol. 2008 Jan;44(1):23-30. Epub 2007 Feb 15.

PMID:
17306611
[PubMed - indexed for MEDLINE]
11.

Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy.

Phan J, Mazloom A, Medeiros LJ, Zreik TG, Wogan C, Shihadeh F, Rodriguez MA, Fayad L, Fowler N, Reed V, Horace P, Dabaja BS.

J Clin Oncol. 2010 Sep 20;28(27):4170-6. doi: 10.1200/JCO.2009.27.3441. Epub 2010 Aug 16.

PMID:
20713859
[PubMed - indexed for MEDLINE]
Free Article
12.

Secondary analysis of Radiation Therapy Oncology Group study (RTOG) 9310: an intergroup phase II combined modality treatment of primary central nervous system lymphoma.

Fisher B, Seiferheld W, Schultz C, DeAngelis L, Nelson D, Schold SC, Curran W, Mehta M.

J Neurooncol. 2005 Sep;74(2):201-5.

PMID:
16193393
[PubMed - indexed for MEDLINE]
13.

[Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].

Yao B, Li YX, Song YW, Jin J, Liu YP, Wang WH, Wang SL, Sun YT, Yu ZH, Liu XF.

Zhonghua Zhong Liu Za Zhi. 2006 Jan;28(1):58-61. Chinese.

PMID:
16737624
[PubMed - indexed for MEDLINE]
14.

Primary diffuse large B-cell lymphoma of the tonsil: is a higher radiotherapy dose required?

Laskar S, Bahl G, Muckaden MA, Nair R, Gupta S, Bakshi A, Gujral S, Shet T, Shrivastava SK, Dinshaw KA.

Cancer. 2007 Aug 15;110(4):816-23.

PMID:
17582622
[PubMed - indexed for MEDLINE]
Free Article
15.
16.

Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy.

Wilder RB, Tucker SL, Ha CS, Rodriguez MA, Hess MA, Cabanillas FF, Cox JD.

Int J Radiat Oncol Biol Phys. 2001 Jan 1;49(1):17-22.

PMID:
11163493
[PubMed - indexed for MEDLINE]
17.

Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapy.

Mundt AJ, Sibley GS, Williams S, Rubin SJ, Heimann R, Halpern H, Weichselbaum RR.

Int J Radiat Oncol Biol Phys. 1994 Aug 30;30(1):151-60.

PMID:
8083108
[PubMed - indexed for MEDLINE]
18.

Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience.

Savage KJ, Al-Rajhi N, Voss N, Paltiel C, Klasa R, Gascoyne RD, Connors JM.

Ann Oncol. 2006 Jan;17(1):123-30. Epub 2005 Oct 19.

PMID:
16236753
[PubMed - indexed for MEDLINE]
Free Article
19.

Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.

Plosker GL, Figgitt DP.

Drugs. 2003;63(8):803-43. Review.

PMID:
12662126
[PubMed - indexed for MEDLINE]
20.

Clinical disparity and favorable prognoses for patients with Waldeyer ring extranodal nasal-type NK/T-cell lymphoma and diffuse large B-cell lymphoma.

Wu RY, Li YX, Wang WH, Jin J, Wang SL, Liu YP, Song YW, Fang H, Ren H, Liu QF, Wang ZY, Qi SN, Lu NN, Chen B, Zhang XM, Zhou LQ, Liu XF, Yu ZH.

Am J Clin Oncol. 2014 Feb;37(1):41-6. doi: 10.1097/COC.0b013e318261084b.

PMID:
22992625
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk